Evaluation of the therapeutic activity of itraconazole in human and experimental chronic infection by Trypanosoma cruzi
Keywords:
Trypanosoma cruzi, Infecções crônicas, experimental e humana, Tratamento, ItraconazolAbstract
Other authors have demonstrated that itraconazole has antiparasitic activity against Trypanosoma cruzi both in vitro and in animal acute infection. Because of these observations, we decided to evaluate the chronic phase of this protozoal disease, since it is the most important form under a clinical and assistential point of view. We studied an infected mouse model as well as human cases of Chagas' disease. One hundred mg/ kg/day by gastric tube, and 100 or 200 mg/day orally were given, respectively, during three months, without showing any beneficial effect, at least with the adopted methodsDownloads
Download data is not yet available.
Downloads
Published
1992-04-01
Issue
Section
Therapeutic Assay
How to Cite
Moreira, A. A. B., Souza, H. B. W. T. de, Amato Neto, V., Matsubara, L., Pinto, P. L. S., Tolezano, J. E., Nunes, E. V., & Okumura, M. (1992). Evaluation of the therapeutic activity of itraconazole in human and experimental chronic infection by Trypanosoma cruzi . Revista Do Instituto De Medicina Tropical De São Paulo, 34(2), 177-180. https://www.revistas.usp.br/rimtsp/article/view/28913